3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
9
Breast Neoplasms
8
Colonic Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Respiratory Aspiration
3
Brain Neoplasms
3
Supratentorial Neoplasms
2
Rectal Neoplasms
2
Pituitary Neoplasms
2
Patient Satisfaction
2
Emergence Delirium
2
Agnosia
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Seizures
1
Respiration Disorders
1
Recovery
1
Rare Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Postoperative Cognitive Complications
1
Polyps
1
Pain, Postoperative
1
Pain
1
Overweight
1
Obesity
1
Neurofibromatoses
1
Interventions
Exercise
4
Counseling
3
Nutrition Assessment
2
Naltrexone
2
Metformin
2
Exenatide
2
Diet
2
Cognitive Behavioral Therapy
2
Caloric Restriction
2
Bupropion
2
sultamicillin
1
licogliflozin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Tobacco Use Cessation Devices
1
Surveys and Questionnaires
1
Sugars
1
Sucrose
1
Standard of Care
1
Resistance Training
1
Psychology, Positive
1
Propofol
1
Motivational Interviewing
1
Mindfulness-Based Stress Reduction
1
Methods
1
Flutamide
1
Ethinyl Estradiol
1
Diet, Mediterranean
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Overweight
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled